Andrew R Judge

Andrew R Judge,

Professor

Department: HP-PHYSICAL THERAPY
Business Phone: (352) 273-9220
Business Email: arjudge@ufl.edu

Teaching Profile

Courses Taught
2010-2011,2014-2017,2016-2021
HSC4970 Public Health and Health Professions Senior Honors Thesis
2013-2016,2020-2022
RSD7979 Advanced Research
2019-2023
GMS6476 Fundamentals of Skeletal Muscle
2013-2014,2019-2020
RSD6910 Supervised Research
2010-2021
PHT6152C Exercise Physiology
2014-2015,2017-2024
GMS6065 Fundamentals of Cancer Biology
2016-2019
RSD6930 Special Topics in Rehabilitation Science
2018
GMS7593 Topics in Pharmacology and Toxicology
2018
GMS7979 Advanced Research
2018
GMS7980 Research for Doctoral Dissertation
2015-2016,2022-2024
RSD7980 Research for Doctoral Dissertation
2015,2021-2023
PHT6153 Physiology for Pt
2011-2014
RSD6905 Individual Work
2011-2012,2014
PHT6935C Seminar
2007
APK2105C Appl Human Phys W/Lab
2021
HSC4913 Supervised Research Experience

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0002-4488-291X

Publications

2024
Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
Journal of cachexia, sarcopenia and muscle. 15(1):149-158 [DOI] 10.1002/jcsm.13390. [PMID] 38123146.
2024
Mitochondrial fusion and altered beta-oxidation drive muscle wasting in a Drosophila cachexia model
EMBO Reports. 25(4):1835-1858 [DOI] 10.1038/s44319-024-00102-z. [PMID] 38429578.
2024
Ursolic Acid Induces Beneficial Changes in Skeletal Muscle mRNA Expression and Increases Exercise Participation and Performance in Dogs with Age-Related Muscle Atrophy
Animals. 14(2) [DOI] 10.3390/ani14020186. [PMID] 38254356.
2023
Blocking muscle wasting via deletion of the muscle-specific E3 ligase MuRF1 impedes pancreatic tumor growth
Communications Biology. 6(1) [DOI] 10.1038/s42003-023-04902-2. [PMID] 37179425.
2023
GADD45A is a mediator of mitochondrial loss, atrophy, and weakness in skeletal muscle
JCI Insight. 8(22) [DOI] 10.1172/jci.insight.171772. [PMID] 37815864.
2023
Low Muscle Mass and Radiodensity Associate with Impaired Pulmonary Function and Respiratory Complications in Patients with Esophageal Cancer.
Journal of the American College of Surgeons. 236(4):677-684 [DOI] 10.1097/XCS.0000000000000535. [PMID] 36728466.
2023
The transcription regulator ATF4 is a mediator of skeletal muscle aging.
GeroScience. 45(4):2525-2543 [DOI] 10.1007/s11357-023-00772-y. [PMID] 37014538.
2022
Biology of Activating Transcription Factor 4 (ATF4) and Its Role in Skeletal Muscle Atrophy.
The Journal of nutrition. 152(4):926-938 [DOI] 10.1093/jn/nxab440. [PMID] 34958390.
2022
Depleting Ly6G Positive Myeloid Cells Reduces Pancreatic Cancer-Induced Skeletal Muscle Atrophy
Cells. 11(12) [DOI] 10.3390/cells11121893. [PMID] 35741022.
2022
Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery
Cancer Medicine. 11(1):50-60 [DOI] 10.1002/cam4.4416. [PMID] 34791809.
2021
FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness
Journal of Cachexia, Sarcopenia and Muscle. 12(2):421-442 [DOI] 10.1002/jcsm.12666. [PMID] 33527776.
2021
Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma.
The oncologist. 26(10):825-e1674 [DOI] 10.1002/onco.13853. [PMID] 34101295.
2021
The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer
Cancers. 13(4) [DOI] 10.3390/cancers13040809. [PMID] 33671939.
2020
Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle
Journal of Cachexia, Sarcopenia and Muscle. 11(3):820-837 [DOI] 10.1002/jcsm.12550. [PMID] 32039571.
2020
MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer
Cancer Research. 80(9):1861-1874 [DOI] 10.1158/0008-5472.can-19-1558.
2020
Nicotine Induces IL-8 Secretion from Pancreatic Cancer Stroma and Worsens Cancer-Induced Cachexia.
Cancers. 12(2) [DOI] 10.3390/cancers12020329. [PMID] 32024069.
2020
Pharmacological targeting of mitochondrial function and reactive oxygen species production prevents colon 26 cancer-induced cardiorespiratory muscle weakness.
Oncotarget. 11(38):3502-3514 [DOI] 10.18632/oncotarget.27748. [PMID] 33014286.
2019
An anti-CRF antibody suppresses the HPA axis and reverses stress-induced phenotypes.
The Journal of experimental medicine. 216(11):2479-2491 [DOI] 10.1084/jem.20190430. [PMID] 31467037.
2019
Cancer cachexia impairs neural respiratory drive in hypoxia but not hypercapnia.
Journal of cachexia, sarcopenia and muscle. 10(1):63-72 [DOI] 10.1002/jcsm.12348. [PMID] 30362273.
2019
Colon 26 adenocarcinoma (C26)-induced cancer cachexia impairs skeletal muscle mitochondrial function and content.
Journal of muscle research and cell motility. 40(1):59-65 [DOI] 10.1007/s10974-019-09510-4. [PMID] 30945134.
2019
IL-8 Released from Human Pancreatic Cancer and Tumor-Associated Stromal Cells Signals through a CXCR2-ERK1/2 Axis to Induce Muscle Atrophy.
Cancers. 11(12) [DOI] 10.3390/cancers11121863. [PMID] 31769424.
2019
Mas Receptor Activation Slows Tumor Growth and Attenuates Muscle Wasting in Cancer.
Cancer research. 79(4):706-719 [DOI] 10.1158/0008-5472.CAN-18-1207. [PMID] 30420474.
2019
MYOD1 functions as a clock amplifier as well as a critical co-factor for downstream circadian gene expression in muscle.
eLife. 8 [DOI] 10.7554/eLife.43017. [PMID] 30789342.
2019
Racial and ethnic disparities in a state-wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities.
Cancer medicine. 8(6):3314-3324 [DOI] 10.1002/cam4.2180. [PMID] 31074202.
2018
Cold shock protein RBM3 attenuates atrophy and induces hypertrophy in skeletal muscle.
Journal of muscle research and cell motility. 39(1-2):35-40 [DOI] 10.1007/s10974-018-9496-x. [PMID] 30051360.
2018
Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.
International journal of molecular sciences. 19(12) [DOI] 10.3390/ijms19123836. [PMID] 30513792.
2018
Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival.
JNCI cancer spectrum. 2(3) [DOI] 10.1093/jncics/pky043. [PMID] 30637373.
2018
Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Journal of cachexia, sarcopenia and muscle. 9(6):1109-1120 [DOI] 10.1002/jcsm.12346. [PMID] 30270531.
2017
A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer.
Surgery. 161(4):930-938 [DOI] 10.1016/j.surg.2016.09.038. [PMID] 27932030.
2017
Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia.
Oncotarget. 8(1):1177-1189 [DOI] 10.18632/oncotarget.13593. [PMID] 27901481.
2017
Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease.
Pancreas. 46(6):813-819 [DOI] 10.1097/MPA.0000000000000843. [PMID] 28609371.
2016
Diaphragm Abnormalities in Patients with End-Stage Heart Failure: NADPH Oxidase Upregulation and Protein Oxidation.
Frontiers in physiology. 7 [DOI] 10.3389/fphys.2016.00686. [PMID] 28119629.
2016
Forelimb muscle plasticity following unilateral cervical spinal cord injury.
Muscle & nerve. 53(3):475-8 [DOI] 10.1002/mus.25007. [PMID] 26662579.
2016
Janus kinase inhibition prevents cancer- and myocardial infarction-mediated diaphragm muscle weakness in mice.
American journal of physiology. Regulatory, integrative and comparative physiology. 310(8):R707-10 [DOI] 10.1152/ajpregu.00550.2015. [PMID] 26864813.
2015
Differential expression of HDAC and HAT genes in atrophying skeletal muscle.
Muscle & nerve. 52(6):1098-101 [DOI] 10.1002/mus.24912. [PMID] 26372908.
2015
Identification of the Acetylation and Ubiquitin-Modified Proteome during the Progression of Skeletal Muscle Atrophy.
PloS one. 10(8) [DOI] 10.1371/journal.pone.0136247. [PMID] 26302492.
2015
NAD(P)H oxidase subunit p47phox is elevated, and p47phox knockout prevents diaphragm contractile dysfunction in heart failure.
American journal of physiology. Lung cellular and molecular physiology. 309(5):L497-505 [DOI] 10.1152/ajplung.00176.2015. [PMID] 26209274.
2014
CrossTalk opposing view: The dominant mechanism causing disuse muscle atrophy is proteolysis.
The Journal of physiology. 592(24):5345-7 [DOI] 10.1113/jphysiol.2014.279406. [PMID] 25512436.
2014
Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.
BMC cancer. 14 [DOI] 10.1186/1471-2407-14-997. [PMID] 25539728.
2014
HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy.
Journal of cell science. 127(Pt 7):1441-53 [DOI] 10.1242/jcs.136390. [PMID] 24463822.
2014
Rapid diaphragm atrophy following cervical spinal cord hemisection.
Respiratory physiology & neurobiology. 192:66-73 [DOI] 10.1016/j.resp.2013.12.006. [PMID] 24341999.
2014
Rebuttal from Michael B. Reid, Andrew R. Judge and Sue C. Bodine.
The Journal of physiology. 592(24) [DOI] 10.1113/jphysiol.2014.284398. [PMID] 25512438.
2014
Transcriptional regulation of myotrophic actions by testosterone and trenbolone on androgen-responsive muscle.
Steroids. 87:59-66 [DOI] 10.1016/j.steroids.2014.05.024. [PMID] 24928725.
2013
Cancer cachexia decreases specific force and accelerates fatigue in limb muscle.
Biochemical and biophysical research communications. 435(3):488-92 [DOI] 10.1016/j.bbrc.2013.05.018. [PMID] 23673294.
2013
Diaphragm and ventilatory dysfunction during cancer cachexia.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 27(7):2600-10 [DOI] 10.1096/fj.12-222844. [PMID] 23515443.
2013
Diaphragm atrophy and contractile dysfunction in a murine model of pulmonary hypertension.
PloS one. 8(4) [DOI] 10.1371/journal.pone.0062702. [PMID] 23614054.
2013
Effect of Trenbolone Enanthate On Protein Degradation in Levator Ani/Bulbocavernosus (Labc) Muscle in Orchiectomized Rats
The FASEB's Journal. 27
2013
Heat Shock Factor-1 Regulates Il-6 Promoter Activity in C2C12 Muscle Myotubes
The FASEB's Journal. 27
2013
Loss of the inducible Hsp70 delays the inflammatory response to skeletal muscle injury and severely impairs muscle regeneration.
PloS one. 8(4) [DOI] 10.1371/journal.pone.0062687. [PMID] 23626847.
2013
Skeletal muscle interleukin-6 regulation in hyperthermia.
American journal of physiology. Cell physiology. 305(4):C406-13 [DOI] 10.1152/ajpcell.00084.2013. [PMID] 23636453.
2013
Temporal Changes in the Acetylation Profile of Skeletal Muscle Proteins During Atrophy
The FASEB's Journal. 27
2013
The Diaphragm Rapidly Increases Expression of Muscle Atrophy Genes Following Acute Cervical Spinal Cord Injury (Csci)
The FASEB's Journal. 27
2012
Determination of gene promoter activity in skeletal muscles in vivo.
Methods in molecular biology (Clifton, N.J.). 798:461-72 [DOI] 10.1007/978-1-61779-343-1_27. [PMID] 22130854.
2012
Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 26(3):987-1000 [DOI] 10.1096/fj.11-189977. [PMID] 22102632.
2012
Long-term perturbation of muscle iron homeostasis following hindlimb suspension in old rats is associated with high levels of oxidative stress and impaired recovery from atrophy.
Experimental gerontology. 47(1):100-8 [DOI] 10.1016/j.exger.2011.10.011. [PMID] 22085543.
2012
Meeting Synopsis: Advances in Skeletal Muscle Biology in Health and Disease (Gainesville, Florida, February 22nd to 24th 2012) – Day 1: “Cell Signaling Mechanisms Mediating Muscle Atrophy and Hypertrophy” and “muscle Force, Calcium Handling, and Stress Response”.
Frontiers in physiology. 3 [DOI] 10.3389/fphys.2012.00200. [PMID] 22701436.
2012
Meeting synopsis: advances in skeletal muscle biology in health and disease (gainesville, Florida, february 22nd to 24th 2012) – day 2: “muscle diseases and regeneration” and “clinical/translational research”.
Frontiers in physiology. 3 [DOI] 10.3389/fphys.2012.00201. [PMID] 22701437.
2012
Oxidative stress and disuse muscle atrophy: cause or consequence?
Current opinion in clinical nutrition and metabolic care. 15(3):240-5 [DOI] 10.1097/MCO.0b013e328352b4c2. [PMID] 22466926.
2012
Putting the spice in weaning*.
Critical care medicine. 40(3):1022-3 [DOI] 10.1097/CCM.0b013e31823e96c2. [PMID] 22343867.
2011
Inhibition of IkappaB kinase alpha (IKKα) or IKKbeta (IKKβ) plus forkhead box O (Foxo) abolishes skeletal muscle atrophy.
Biochemical and biophysical research communications. 405(3):491-6 [DOI] 10.1016/j.bbrc.2011.01.059. [PMID] 21256828.
2011
IκBα degradation is necessary for skeletal muscle atrophy associated with contractile claudication.
American journal of physiology. Regulatory, integrative and comparative physiology. 300(3):R595-604 [DOI] 10.1152/ajpregu.00728.2010. [PMID] 21209383.
2011
p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle.
American journal of physiology. Cell physiology. 300(6):C1490-501 [DOI] 10.1152/ajpcell.00255.2010. [PMID] 21389279.
2010
FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70.
American journal of physiology. Cell physiology. 298(1):C38-45 [DOI] 10.1152/ajpcell.00315.2009. [PMID] 19864323.
2010
Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.
Ageing research reviews. 9(4):369-83 [DOI] 10.1016/j.arr.2010.04.004. [PMID] 20438881.
2010
p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting.
American journal of physiology. Cell physiology. 298(3):C542-9 [DOI] 10.1152/ajpcell.00192.2009. [PMID] 19955483.
2010
Ros-mediated activation of NF-kappaB and Foxo during muscle disuse.
Muscle & nerve. 41(1):110-3 [DOI] 10.1002/mus.21526. [PMID] 19813194.
2009
Calpain-1 is required for hydrogen peroxide-induced myotube atrophy.
American journal of physiology. Cell physiology. 296(2):C363-71 [DOI] 10.1152/ajpcell.00497.2008. [PMID] 19109522.
2009
Hsp27 inhibits IKKbeta-induced NF-kappaB activity and skeletal muscle atrophy.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 23(10):3415-23 [DOI] 10.1096/fj.08-124602. [PMID] 19528257.
2009
Hsp70 prevents disuse muscle atrophy in senescent rats.
Biogerontology. 10(5):605-11 [DOI] 10.1007/s10522-008-9203-1. [PMID] 19083119.
2008
Antioxidants attenuate oxidative damage in rat skeletal muscle during mild ischaemia.
Experimental physiology. 93(4):479-85 [DOI] 10.1113/expphysiol.2007.040972. [PMID] 18223025.
2008
Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 22(11):3836-45 [DOI] 10.1096/fj.08-110163. [PMID] 18644837.
2008
The in vivo rat muscle force model is a reliable and clinically relevant test of consistency among botulinum toxin preparations.
Toxicon : official journal of the International Society on Toxinology. 52(3):455-64 [DOI] 10.1016/j.toxicon.2008.06.021. [PMID] 18639570.
2008
The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type.
Vascular and endovascular surgery. 42(2):101-12 [DOI] 10.1177/1538574408315995. [PMID] 18390972.
2007
Mitochondriopathy of peripheral arterial disease.
Vascular. 15(6):336-43 [PMID] 18053417.
2007
The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction.
Vascular and endovascular surgery. 41(6):481-9 [DOI] 10.1177/1538574407311106. [PMID] 18166628.
2006
Mitochondrial defects and oxidative damage in patients with peripheral arterial disease.
Free radical biology & medicine. 41(2):262-9 [PMID] 16814106.
2005
Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle.
Toxicon : official journal of the International Society on Toxinology. 46(2):196-203 [PMID] 15975617.
2005
Life long calorie restriction increases heat shock proteins and proteasome activity in soleus muscles of Fisher 344 rats.
Experimental gerontology. 40(1-2):37-42 [PMID] 15664730.
2004
Short-term CR decreases cardiac mitochondrial oxidant production but increases carbonyl content.
American journal of physiology. Regulatory, integrative and comparative physiology. 286(2):R254-9 [PMID] 14592935.
2004
Xanthine oxidase and activated neutrophils cause oxidative damage to skeletal muscle after contractile claudication.
American journal of physiology. Heart and circulatory physiology. 286(1):H252-6 [PMID] 12969896.
2003
Oxidative damage to skeletal muscle following an acute bout of contractile claudication.
Atherosclerosis. 171(2):219-24 [PMID] 14644390.

Grants

May 2024 ACTIVE
Fuller T32 renewal
Role: Co-Investigator
Funding: NATL INST OF HLTH NICHD
Sep 2023 ACTIVE
Matricellular proteins of the CNN family as regulators of tumor-induced cachexia
Role: Co-Investigator
Funding: NATL INST OF HLTH NCI
May 2023 ACTIVE
Development of Novel Therapeutics for Cancer Cachexia
Role: Principal Investigator
Funding: EMMYON via NATL INST OF HLTH NCI
Aug 2022 ACTIVE
The Complement System and Cancer Cachexia
Role: Principal Investigator
Funding: NATL INST OF HLTH NIAMS
Aug 2021 ACTIVE
Understanding and Improving Therapies for the Muscular Dystrophies
Role: Other
Funding: NATL INST OF HLTH NIAMS
May 2021 – Apr 2024
Ursolic acid as a countermeasure to cancer cachexia
Role: Principal Investigator
Funding: FL DEPT OF HLTH BANKHEAD-COLEY CANCER RE
Apr 2021 ACTIVE
Team-based Interdisciplinary Cancer Research Training Program
Role: Co-Investigator
Funding: NATL INST OF HLTH NCI
Jul 2020 – Jun 2023
OR_DRPD_ROF2020:The Role of Trim63 in Cancer Cachexia
Role: Principal Investigator
Funding: UF RESEARCH
Aug 2019 – Oct 2020
Activation of Complement System Mediates Skeletal Muscle Wasting and Pathology in Pancreatic Cancer Cachexia
Role: Other
Funding: UF FOUNDATION via CIRCLE OF HOPE FOR CANCER RES INC
Jul 2019 – Jun 2022
UF Health Cancer Center Pilot Projects funded by UF Foundation Allocated Funds
Role: Project Manager
Funding: UF FOUNDATION
May 2019 – Apr 2024
Interdisciplinary Training in Neuromuscular Plasticity and Rehabilitation
Role: Co-Investigator
Funding: NATL INST OF HLTH NICHD
Mar 2019 – May 2021
Ventilator-induced diaphragm dysfunction: role of calpain signaling
Role: Other
Funding: NATL INST OF HLTH NIAMS
May 2018 – Sep 2021
The Florida Pancreas Collaborative Next-Generation Biobank-Reducing Health Disparities and Improving Survival in Pancreatic Cancer
Role: Principal Investigator
Funding: H LEE MOFFITT CANCER CTR & RES INST via FL DEPT OF HLTH BIOMED RES PGM/J&E KING
Sep 2017 – Aug 2023
FoxO signaling and skeletal muscle atrophy
Role: Principal Investigator
Funding: NATL INST OF HLTH NIAMS
Mar 2017 – Dec 2020
Initiating Mechanisms of Cancer Cachexia
Role: Principal Investigator
Funding: FL DEPT OF HLTH BANKHEAD-COLEY CANCER RE
Jun 2016 – Feb 2019
Advanced cancers secrete GDF11 to induce cachexia
Role: Project Manager
Funding: UF DSR OPPORTUNITY FUND
Jan 2016 – Dec 2021
Reactive Oxygen Species and Respiratory Muscle Dysfunction in Heart Failure
Role: Project Manager
Funding: NATL INST OF HLTH NHLBI
Jan 2016 – Dec 2021
ufhcc-ioa cancer-aging collaborative team grants
Role: Project Manager
Funding: UF HEALTH SHANDS HOSPITAL
Nov 2015 – Nov 2018
The role of muscle cachexia in pancreatic cancer
Role: Project Manager
Funding: THE V FOU FOR CANCER RESEARCH
Aug 2015 – Jul 2021
Failed Regeneration in the Muscular Dystrophies: Inflammation, Fibrosis and Fat
Role: Co-Investigator
Funding: NATL INST OF HLTH NIAMS
Apr 2015 – Mar 2018
Dysregulation of sarcomere stabilizing proteins cause muscle atrophy and weakness during cancer cachexia
Role: Principal Investigator
Funding: NATL INST OF HLTH NCI
Apr 2015 – Jun 2021
Clinical and Translational Science Institute (CTSI)
Role: Project Manager
Funding: UF DIV OF SPONSORED RES MATCHING FUNDS
Jan 2015 ACTIVE
UF Health Cancer Center Bridge Seed Grant funded through the Florida Consortium of National Cancer Institute Centers Program
Role: Project Manager
Funding: UF HEALTH SHANDS HOSPITAL
Apr 2013 – Mar 2019
Mechanisms of Exercise Protection in Ventilator-Induced Diaphragm Dysfunction
Role: Project Manager
Funding: NATL INST OF HLTH NIAMS
Aug 2011 – May 2017
FOXO signaling and skeletal muscle atrophy
Role: Principal Investigator
Funding: NATL INST OF HLTH NIAMS

Education

Postdoc Muscle Biology
2006 · Boston University
Ph.D. Exercise Physiology
2003 · University of Florida
M.Ed. Exercise Physiology
1999 · McNeese State University
B.S.
1996 · Loughborough University

Contact Details

Phones:
Business:
(352) 273-9220
Emails:
Business:
arjudge@ufl.edu
Addresses:
Business Mailing:
J303 1275 CENTER DRIVE
GAINESVILLE FL 326100001
Business Street:
25 FLG
GAINESVILLE FL 32611